Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1

The remarkable heterogeneity of glioblastoma, across patients and over time, is one of the main challenges in precision diagnostics and treatment planning. Non-invasive in vivo characterization of this heterogeneity using imaging could assist in understanding disease subtypes, as well as in risk-str...

Descripción completa

Detalles Bibliográficos
Autores principales: Rathore, Saima, Akbari, Hamed, Rozycki, Martin, Abdullah, Kalil G., Nasrallah, MacLean P., Binder, Zev A., Davuluri, Ramana V., Lustig, Robert A., Dahmane, Nadia, Bilello, Michel, O’Rourke, Donald M., Davatzikos, Christos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865162/
https://www.ncbi.nlm.nih.gov/pubmed/29572492
http://dx.doi.org/10.1038/s41598-018-22739-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865162/
https://www.ncbi.nlm.nih.gov/pubmed/29572492
http://dx.doi.org/10.1038/s41598-018-22739-2

Ejemplares similares